Heather Greenlee

TL;DR: In this article, the authors provided updated clinical practice guidelines from the Society for Integrative Oncology on the use of integrative therapies for specific clinical indications during and after breast cancer treatment, including anxiety/stress, depression/mood disorders, fatigue, quality of life/physical functioning, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapyinduced peripheral neuropathy, pain, and sleep disturbance.

TL;DR: This study suggests that AI-related joint symptoms are more prevalent than what has been described previously in clinical trials and the success of AI therapy depends on patients' ability to adhere to treatment recommendations; therefore, additional studies of interventions that may alleviate these symptoms are needed.

TL;DR: The complete version of the NCCN Guidelines for Adult Cancer Pain addresses additional aspects of this topic, including pathophysiologic classification of cancer pain syndromes, comprehensive pain assessment, management of pain crisis, ongoing care for cancer pain, pain in cancer survivors, and specialty consultations.

TL;DR: Women with AI-induced arthralgias treated with TA had significant improvement of joint pain and stiffness, which was not seen with SA, and Acupuncture is an effective and well-tolerated strategy for managing this common treatment-related side effect.

TL;DR: Specific integrative therapies can be recommended as evidence-based supportive care options during breast cancer treatment and require further investigation via well-designed controlled trials with meaningful outcomes.